stockmarketproxy
/
RVTYNYSESEC EDGAREDGAR

REVVITY, INC.

Laboratory Analytical Instruments·WALTHAM, MA·FY end 12/29·CIK 31791
OverviewFinancialsCompensationGovernanceInsidersFilings

Financials

5-year history · USD
MetricFY 2025FY 2024FY 2023FY 2022FY 2021Trend
Revenue$2.9B$2.8B$2.8B$741.2M$5.1B
Gross Profit———$436.3M——
Operating Income$356.6M$346.7M$300.6M$137.5M$1.3B
Net Income$241.2M$270.4M$693.1M$127.7M$943.2M
Operating CF$582.9M$628.3M$91.3M$679.8M$1.4B
Capex$73.5M$86.6M$81.4M$85.6M$99.9M
Free Cash Flow$509.4M$541.7M$9.9M$594.2M$1.3B
Buybacks$820.8M$369.6M$388.9M$80.6M$73.1M
Dividends$32.8M$34.5M$35.0M$35.3M$32.4M
Gross Margin———58.9%——
Operating Margin12.5%12.6%10.9%18.5%26.3%
Net Margin8.4%9.8%25.2%17.2%18.6%
FCF Margin17.8%19.7%0.4%80.2%25.9%
R&D / Revenue7.6%7.1%7.9%29.9%5.4%
Effective Tax10.6%10.5%1.9%21.3%26.3%
Debt / Equity0.360.410.901.131.40
Buybacks / FCF161.1%68.2%3926.5%13.6%5.6%

Peer comparison

Laboratory Analytical Instruments · 5 peers
CEO Pay Ratio
RVTY
239:1
ILMN
97:1
BIO
97:1
MTD
118:1
AVTR
148:1
A
155:1
CEO total comp
RVTY
$14M
ILMN
$11M
BIO
$8M
MTD
$7M
AVTR
$6M
A
$0M
Net Margin
RVTY
8.4%
ILMN
19.6%
BIO
29.4%
MTD
21.6%
AVTR
-8.1%
A
18.8%